Crinetics Pharmaceuticals (CRNX) Amortizatization of Intangibles (2019 - 2026)

Crinetics Pharmaceuticals' Amortizatization of Intangibles history runs 8 years deep, the most recent figure standing at $2.2 million for Q1 2026.

• In Q1 2026, Amortizatization of Intangibles fell 49.27% year-over-year to $2.2 million; the TTM figure through Mar 2026 stood at $13.3 million (down 14.17% YoY), while the FY2025 annual figure was $15.4 million, up 3.31% from the prior year.
• Amortizatization of Intangibles for Q1 2026 stood at $2.2 million, down from $2.7 million in the prior quarter.
• The five-year high for Amortizatization of Intangibles was $4.7 million in Q2 2025, with the low at -$322000.0 in Q1 2022.
• The 5-year median for Amortizatization of Intangibles is $2.7 million (2025), against an average of $2.3 million.
• The sharpest annual moves came in 2022 and 2023: Amortizatization of Intangibles slumped 287.95% in 2022, then surged 921.08% in 2023.
• Crinetics Pharmaceuticals' Amortizatization of Intangibles stood at $351000.0 in 2022, then soared by 921.08% to $3.6 million in 2023, then rose by 16.16% to $4.2 million in 2024, then slumped by 34.33% to $2.7 million in 2025, then decreased by 18.8% to $2.2 million in 2026.
• Business Quant data shows CRNX's Amortizatization of Intangibles at $2.2 million in Q1 2026, $2.7 million in Q4 2025, and $3.6 million in Q3 2025.